L Alanosine Therapy for Mtap Deficient Lung Cancer

Carrera, Carlos J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Exploratory/Developmental Grants (R21)
• Project #: 1R21CA068260-01A1
• Application #: 2112164
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Project Start: 1996-04-19
• Project End: 1998-03-31
• Budget Start: 1996-04-19
• Budget End: 1997-03-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: University of California San Diego
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 077758407
• City: La Jolla
• State: CA
• Country: United States
• Zip Code: 92093

Publications

Schmid, M; Malicki, D; Nobori, T et al. (1998) Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Oncogene 17:2669-75